# OnCo record flare-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/flare-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "flare-therapeutics" ;
  schema:name "Flare Therapeutics"@en ;
  schema:alternateName "Flare Therapeutics Inc."@en, "FlareTx"@en ;
  schema:description "Flare Therapeutics makes small-molecule drugs aimed at transcription factors, the proteins that switch genes on and off. Its two drugs in early trials are for advanced bladder (urothelial) cancer and for prostate cancer that has stopped responding to hormone treatment."@en ;
  schema:url <https://onco.cc/companies/flare-therapeutics/>, <https://www.flaretx.com/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.flaretx.com/>, <https://www.flaretx.com/pipeline/>, <https://www.flaretx.com/fx-909/>, <https://www.flaretx.com/pipeline/fx-111/>, <https://www.flaretx.com/about/>, <https://www.thirdrockventures.com/portfolio/flare-therapeutics> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/urothelial/>, <https://onco.cc/cancers/prostate-mcrpc/> ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/> ;
  onco:targets <https://onco.cc/targets/pparg/>, <https://onco.cc/targets/androgen-receptor/> ;
  onco:drugs <https://onco.cc/drugs/fx-909/>, <https://onco.cc/drugs/fx-111/> .